Pennsylvania · Nonprofit
DAVOS ALZHEIMER'S COLLABORATIVE INC
DAVOS ALZHEIMER'S COLLABORATIVE INC (Pennsylvania) receives grants from 7 organizations whose IRS filings report $8,774,108 to it, the largest being ALZHEIMER'S DRUG DISCOVERY FOUNDATION ($5,000,000). 2 of them have funded it in more than one year.
- Revenue FY2025
- $12M
- Funders on record
- 7
- Grants received
- $8.8M
- Net assets
- $7.9M
What Davos Alzheimer's Collaborative Inc does
Mission
Dac is leading the largest global response of its kind, driving scientific discovery and aligning health systems to help people worldwide, including those in low resourced environments left out of previous efforts to fight alzheimer's. (see schedule o)we are committed to transforming alzheimer's research, prevention and care through proven private-public models, such as gavi, cepi and the global fund.
As stated on its FY2025 Form 990.
Programs
The davos alzheimer's collaborative's system preparedness program aims to strengthen healthcare systems' ability to identify and address alzheimer's disease (ad) and related dementias (adrd) early. Key initiatives include the early detection fellowship, which offers technical assistance and funding to healthcare organizations (hcos) to implement the early detection blueprint, fostering collaboration among selected sites to overcome barriers and enhance early detection. The program also includes the brain health navigator initiative, designed to pilot a brain health navigator model in six hcos to support timely care for patients with cognitive decline. Additionally, the accurate diagnosis program aims to increase the use of new diagnostic tools, helping healthcare systems adopt more effective methods for diagnosing ad/adrd. These efforts are supported by significant funding and are intended to improve system preparedness through outreach, training, and the creation of practical toolkits for healthcare providers.overall, outputs include peer-reviewed publications, symposiums, policy communications, and an open-access "blueprint" for ad/adrd early detection and system preparedness.…
$13,167,569 spentof which $3,538,155 as grants89% of program spendingThe davos alzheimer's collaborative's global cohort development program focuses on building a diverse and sustainable network of cohorts to advance alzheimer's disease (ad) and related dementias (adrd) research. This includes partnerships such as the collaboration with aga khan university in nairobi, kenya, where cognitive tests, saliva-based polygenic risk scores, and digital cognitive assessments are being validated in east african populations to create a clinical trial-ready cohort. In south korea, dac has acquired blood samples from 300 participants in a highly characterized cohort, advancing the validation of blood-based biomarkers (bbms) for global use. The project also includes access to 1,000 blood samples from a long-standing cohort in the latam/caribbean region for ad blood biomarker validation, as well as a large-scale clinical trial recruitment effort in the dominican republic, with over 14,000 participants across urban and rural settings.further expanding global research, dac is developing scalable approaches in egypt for early detection, monitoring, and risk reduction of ad, while in india, the "eye-dea study" is using cataract surgery clinics to assess ocular,…
$1,667,040 spentof which $4,000 as grants$60,000 earned by the program11% of program spendingThe davos alzheimer's collaborative's global clinical trial program is maintaining a network of more than 30 european sites organized to accelerate studies and implement novel trial designs. This effort is part of dac's broader goal to build infrastructure for future pharmacological and non-pharmacological trials globally. Through the global cohort development program, dac is working to create clinical trial-ready populations by 2026, ensuring that diverse and well-characterized cohorts are prepared for both types of interventions. This will expand opportunities for global clinical trials, enhancing the ability to test new treatments and approaches in alzheimer's disease (ad) and related dementias (adrd) across varied populations and settings.
The 3 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $14,834,609.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $13M to $8.5M (−37%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
98% of DAVOS ALZHEIMER'S COLLABORATIVE INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
George Vradenburg
Chair & president
As listed on its FY2025 Form 990.
Who funds it, year by year
2021 → 2023: the base held at 2 funders, grant income rose $2.5M → $2.7M.
1 of 7 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 2% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of DAVOS ALZHEIMER'S COLLABORATIVE INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
DAVOS ALZHEIMER'S COLLABORATIVE INC leans on a few funders — its largest provides 57% of grant income and the top three 89%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
94% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund DAVOS ALZHEIMER'S COLLABORATIVE INC.
Largest funder’s share by year: 2021 91% · 2022 100% · 2023 93% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
DAVOS ALZHEIMER'S COLLABORATIVE INC draws 100% of its grant income from funders outside Pennsylvania, across 6 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $150k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
DAVOS ALZHEIMER'S COLLABORATIVE INC holds deeper cash reserves than three-quarters of the 2,969 health nonprofits its size.
this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025
Organizations like DAVOS ALZHEIMER'S COLLABORATIVE INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Pennsylvania
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
92% of spending goes to programs.
Governance
Footprint & structure
Part of a family of 1 related entity
- Davos Alzheimer's Collaborative (Geneve) · exempt
Screen this organization
A dated, signed PDF of the compliance screen for DAVOS ALZHEIMER'S COLLABORATIVE INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds DAVOS ALZHEIMER'S COLLABORATIVE INC?
- DAVOS ALZHEIMER'S COLLABORATIVE INC (Pennsylvania) receives grants from 7 organizations whose IRS filings report $8,774,108 to it, the largest being ALZHEIMER'S DRUG DISCOVERY FOUNDATION ($5,000,000). 2 of them have funded it in more than one year.
- How many funders does DAVOS ALZHEIMER'S COLLABORATIVE INC have?
- IRS filings report 7 organizations giving $8,774,108 in grants to DAVOS ALZHEIMER'S COLLABORATIVE INC, 2 of which have funded it in more than one year.
- Who is the largest funder of DAVOS ALZHEIMER'S COLLABORATIVE INC?
- ALZHEIMER'S DRUG DISCOVERY FOUNDATION is the largest funder on record, with $5,000,000 in grants. The full list of funders is on this page.
- How can an organization like DAVOS ALZHEIMER'S COLLABORATIVE INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Pennsylvania. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2021–2025), and the filings of 7 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing